Sinovac Biotech Ltd (SVA) stock
SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.47+0.00 (0.00%)
Close on Nov 13, 2026Market cap $464.94MP/E –Yield 850.08%
Sinovac Biotech total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Sinovac Biotech's total debt was $3.32M at Dec 31, 2018. For fiscal 2018 it was $3.32M, down 81.7% from the year before. The highest annual figure on record is $47.38M in fiscal 2014.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $3.32M | -81.7% |
| FY2017 | Dec 31, 2017 | $18.15M | -42.0% |
| FY2016 | Dec 31, 2016 | $31.28M | +43.6% |
| FY2015 | Dec 31, 2015 | $21.78M | -54.0% |
| FY2014 | Dec 31, 2014 | $47.38M | +192.1% |
| FY2013 | Dec 31, 2013 | $16.22M | +387.1% |
| FY2012 | Dec 31, 2012 | $3.33M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $3.32M | -93.0% |
| Q4 FY2017 | Dec 31, 2017 | $18.15M | +11.9% |
| Q4 FY2016 | Dec 31, 2016 | $31.28M | +839.6% |
| Q4 FY2015 | Dec 31, 2015 | $21.78M | – |
| Q4 FY2014 | Dec 31, 2014 | $47.38M | – |
| Q4 FY2013 | Dec 31, 2013 | $16.22M | – |
| Q4 FY2012 | Dec 31, 2012 | $3.33M | – |
See a number that looks wrong?